![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 49, 46445-46452, December 7, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Departments of Medicine and Molecular & Cellular Biology,
Baylor College of Medicine, Houston, Texas 77030
Mammalian homologues of DnaJ proteins, also known
as Hsp40 proteins, are co-chaperonins that complement Hsp70 chaperone
function. Using the yeast two-hybrid system, we cloned an
apolipoprotein (apo) B mRNA editing complementation protein, called
apobec-1-binding protein-2 (ABBP-2), and found that it is a Class II
DnaJ homologue. ABBP-2 binds to apobec-1, the mammalian apoB mRNA
editase, via its J domain and neighboring G/F domain. It is a
ubiquitously expressed protein, and, by transfection analysis of
GFP-ABBP-2, we found that the protein is located in both the nucleus
and cytosol of transfected cells, with predominance in the nucleus.
Down-regulation of ABBP-2 expression in cultured cells inhibits
endogenous apobec-1-mediated apoB mRNA editing. Like other Hsp40
proteins, ABBP-2 binds to Hsp70 and has ATPase-stimulating activity.
Apobec-1-mediated apoB mRNA editing activity of in
vitro tissue extracts requires the presence of Hsp70/ABBP-2.
Although exogenously added ATP is not required for editing activity,
removal of the endogenous ATP present in these extracts, which disrupts
ABBP-2-Hsp70 interaction, completely inhibits editing. ABBP-2 differs
from previously described auxiliary proteins (ABBP-1, ACF, and GRY-RBP)
in that it does not contain any RNA recognition motifs. Not only is
ABBP-2 required for efficient apoB mRNA editing, this newly
discovered apobec-1-binding protein may help determine the subcellular
distribution and trafficking of apobec-1 via its interaction with the
chaperonin Hsp70.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AY054981.
A DnaJ Protein, Apobec-1-binding Protein-2, Modulates
Apolipoprotein B mRNA Editing*
*
This work was supported by National Institutes of Health
Grant HL-56668.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Depts. of Medicine and
Molecular & Cellular Biology, Baylor College of Medicine, One Baylor
Plaza, Houston, TX 77030. Tel.: 713-798-4478; Fax: 713-798-8764;
E-mail: lchan@bcm.tmc.edu.
This article has been cited by other articles:
![]() |
D. N. Hebert and M. Molinari In and Out of the ER: Protein Folding, Quality Control, Degradation, and Related Human Diseases Physiol Rev, October 1, 2007; 87(4): 1377 - 1408. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Chen, T. L. Eggerman, and A. P. Patterson ApoB mRNA editing is mediated by a coordinated modulation of multiple apoB mRNA editing enzyme components Am J Physiol Gastrointest Liver Physiol, January 1, 2007; 292(1): G53 - G65. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shen and L. M. Hendershot ERdj3, a Stress-inducible Endoplasmic Reticulum DnaJ Homologue, Serves as a CoFactor for BiP's Interactions with Unfolded Substrates Mol. Biol. Cell, January 1, 2005; 16(1): 40 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. Saha, H. Kojima, J. Martinez-Botas, A. L. Sunehag, and L. Chan Metabolic Adaptations in the Absence of Perilipin: INCREASED {beta}-OXIDATION AND DECREASED HEPATIC GLUCOSE PRODUCTION ASSOCIATED WITH PERIPHERAL INSULIN RESISTANCE BUT NORMAL GLUCOSE TOLERANCE IN PERILIPIN-NULL MICE J. Biol. Chem., August 20, 2004; 279(34): 35150 - 35158. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Schrofelbauer, D. Chen, and N. R. Landau From The Cover: A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif) PNAS, March 16, 2004; 101(11): 3927 - 3932. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Sowden, D. M. Lehmann, X. Lin, C. O. Smith, and H. C. Smith Identification of Novel Alternative Splice Variants of APOBEC-1 Complementation Factor with Different Capacities to Support Apolipoprotein B mRNA Editing J. Biol. Chem., January 2, 2004; 279(1): 197 - 206. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Lau and L. Chan Involvement of a Chaperone Regulator, Bcl2-associated Athanogene-4, in Apolipoprotein B mRNA Editing J. Biol. Chem., December 26, 2003; 278(52): 52988 - 52996. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Blanc and N. O. Davidson C-to-U RNA Editing: Mechanisms Leading to Genetic Diversity J. Biol. Chem., January 10, 2003; 278(3): 1395 - 1398. [Full Text] [PDF] |
||||
![]() |
K. Ma, A. Cabrero, P. K. Saha, H. Kojima, L. Li, B. H.-J. Chang, A. Paul, and L. Chan Increased beta -Oxidation but No Insulin Resistance or Glucose Intolerance in Mice Lacking Adiponectin J. Biol. Chem., September 13, 2002; 277(38): 34658 - 34661. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lellek, S. Welker, I. Diehl, R. Kirsten, and J. Greeve Reconstitution of mRNA Editing in Yeast Using a Gal4-ApoB-Gal80 Fusion Transcript as the Selectable Marker J. Biol. Chem., June 21, 2002; 277(26): 23638 - 23644. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |